H15.051
Scleromalacia perforans, right eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Scleromalacia perforans is a rare and serious eye condition characterized by thinning and perforation of the sclera, the white outer layer of the eye. When affecting the right eye, it can lead to vision problems and potential eye damage if not diagnosed and managed appropriately. This condition is often linked to autoimmune disorders and requires medical attention to prevent complications.
Causes & Symptoms
Clinical Causes: Autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, or granulomatosis with polyangiitis Chronic inflammatory conditions affecting the eye Previous eye injury or trauma Infections that lead to scleral thinning Idiopathic cases where the exact cause is unknown
Key Symptoms: Gradual decrease in vision or visual disturbances Localized pain or discomfort in the affected eye Unusual eye appearance, such as thinning or bluish hue of the sclera Possible visible thinning or perforation of the sclera Light sensitivity or photophobia
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive eye examination by an ophthalmologist, including slit-lamp biomicroscopy to assess the scleral tissue. Additional tests may include imaging studies such as ultrasound or optical coherence tomography (OCT). Blood tests to identify underlying autoimmune conditions may also be recommended. A detailed patient history is crucial to determine potential causes or contributing factors.
Treatment Protocols: Managing scleromalacia perforans involves addressing the underlying cause when possible, particularly autoimmune conditions. Treatment options may include:
Clinical Advice & FAQs
Billing Guidance
Is H15.051 a billable ICD-10 code?
Yes, H15.051 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H15.051?
Clinical documentation must specify the nature of Scleromalacia perforans, right eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference